Clinical Trial: A Study of Minirin Melt in Patients With Nocturia
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: Minirin Melt Tolerance With Nocturia in the Common Practice Conditions in Czech Republic
Brief Summary: This is a confirmation of safety profile for Minirin Melt in clinical practice.
Detailed Summary:
Sponsor: Ferring Pharmaceuticals
Current Primary Outcome: Verify the safety profile [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Safety aspect of dosage [ Time Frame: 12 months ]
Original Secondary Outcome: Same as current
Information By: Ferring Pharmaceuticals
Dates:
Date Received: October 5, 2010
Date Started: September 2008
Date Completion:
Last Updated: January 3, 2014
Last Verified: January 2014